Clinical Trial

Qualitative Effects of AEF0217 in Down Syndrome People

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
Following the AEF0217-102 trial (NCT05748405), which investigated the effects of AEF0217 versus placebo, participants with Down syndrome and their caregivers who took part in the trial are invited to share their perceptions of what they experienced or observed, in an exploratory manner. This qualitative study collects information through a specific questionnaire developed for this purpose.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Enrolling by Invitation 2026-04-09
Trial Details
NCT Number NCT07413224
Lead Sponsor Aelis Farma
Collaborators: Hospital del Mar Research Institute (IMIM)
Conditions Down Syndrome (Trisomy 21)
Enrollment 28 participants
Start Date 2026-03-01
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-08